Related Experiment Video
Updated: Jul 15, 2026
06:05
Modified Radical Neck Dissection for Cervical Metastasis
Published on: February 20, 2026
Salvage Neck Dissection in Recurrent Head and Neck Squamous Cell Carcinoma After Primary Radiotherapy (RESCUE): An
Andrew Williamson1,2, Sarah Burton1, Zayn Rajan3
1International Centre for Recurrent Head and Neck Cancer (IReC), Department of Head and Neck Surgery, The Royal Marsden Hospital, London, UK.
Head & Neck
|July 14, 2026
Summary
Salvage neck dissection (sND) for recurrent head and neck squamous cell carcinoma (rHNSCC) shows similar survival regardless of dissection extent. Occult disease in clinically negative lymph nodes is rare, suggesting observation may be safe for these patients.
Area of Science:
- Oncology
- Surgical Oncology
- Head and Neck Surgery
Background:
- Recurrent head and neck squamous cell carcinoma (rHNSCC) presents a significant clinical challenge.
- Salvage neck dissection (sND) is a crucial treatment modality for rHNSCC.
- Evaluating sND outcomes based on lymph node status is essential for treatment optimization.
Purpose of the Study:
- To investigate the survival outcomes of sND in rHNSCC patients.
- To compare outcomes between clinically node-positive (cN+) and clinically node-negative (cN0) cervical lymph nodes.
- To assess the impact of sND extent on patient survival.
Main Methods:
- Retrospective multicentre observational cohort study.
- Inclusion of patients undergoing sND for cN0 or cN+ rHNSCC (2016-2022).
- Survival analysis stratified by nodal status and sND extent (superselective, selective, radical/modified radical).
Main Results:
- 235 sNDs analyzed; 53.8% cN0 and 46.2% cN+.
- Superselective sND had shorter inpatient stays than selective (15 vs. 18 days).
- Five-year survival rates: Overall 63.3%, Disease-Free 53.0%, Disease-Specific 74.2%, Regional Recurrence-Free 56.9%. No significant survival differences based on sND extent or between selective/superselective sND and observation in cN0 cases.
Conclusions:
- Occult metastatic disease in cN0 cervical lymph nodes is uncommon in rHNSCC.
- Clinical observation may be a safe option for cN0 rHNSCC patients.
- Conservative sND approaches do not compromise disease control or survival outcomes in rHNSCC.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...